Skip to content

Hemorrhoids: Options of Traditional Hemorrhoidectomy

Evaluation of Hemorrhoidectomy Techniques: Scalpel and Electrosurgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06132152
Enrollment
70
Registered
2023-11-15
Start date
2023-12-01
Completion date
2024-11-01
Last updated
2023-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoids, Open Hemorrhoidectomy

Keywords

symptomatic hemorrhoids, open hemorrhoidectomy, postoperative pain, electrosurgery

Brief summary

The goal of this prospective clinical trial is to compare the outcomes of several technical options of open hemorrhoidectomy in patients with symptomatic hemorrhoids. Randomly allocated participants will undergo surgical treatment for hemorrhoids with one technical option of open hemorrhoidecomy: with 'cold' scalpel or electrosurgical instruments. All information to evaluate outcomes between the groups will be collected before surgery and 1 week and 30 days after surgery.

Detailed description

This is a single-center prospective randomized controlled study will be conducted on the basis of the surgical department. Patients with symptomatic hemorrhoids and who will be intended for surgical treatment (open hemorrhoidectomy) will be randomly allocated to one of the group. Prior to surgery the demographic and clinical data will be collected. Open hemorrhoidectomy under spinal anesthesia will be performed with one of the technical options according to the patient's group: * hemorrhoidectomy with 'cold' scalpel for cutting the perianal skin and anal mucose * hemorrhoidectomy with electrosurgical scalpel for cutting the perianal skin and anal mucose. Intraoperative and postoperative data will be collected during first week after surgery and 30 days after surgery. Then the primary and secondary outcomes are evaluated between the groups.

Interventions

PROCEDUREOpen hemorrhoidectomy with 'cold' scalpel

Open hemorrhoidectomy will be performed in traditional way, including radial skin-mucosal excision of enlarged hemorrhoids with ligation of the vascular pedicle. 'Cold' scalpel will be used for cutting the perianal skin and anal mucose. To stop and prevent bleeding the monopolar coagulation may be used but on low energy level and with no touching the skin and mucose.

PROCEDUREOpen hemorrhoidectomy with electrosurgical scalpel

Open hemorrhoidectomy will be performed in traditional way, including radial skin-mucosal excision of enlarged hemorrhoids with ligation of the vascular pedicle. Electrosurgical scalpel will be used during all steps including cutting the perianal skin and anal mucose and to stop and prevent bleeding.

Sponsors

Center of Endourology Endocenter
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Before the operation, all patients are scheduled to perform an open hemorrhoidectomy, which includes radial skin-mucosal excision of enlarged hemorrhoids with ligation of the vascular pedicle. Patients are not informed about which instrument will be used. All collected information will be stored in electronic databases, where patient names and group numbers are anonymized and encrypted. Thus, during the statistical calculation, a person will not know about the name of the group.

Intervention model description

In case of meeting inclusion criteria of patient the selection of the group will be determined by randomization, so both groups will be recruited simultaneously

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients over 18 years old * Diagnosed symptomatic hemorrhoidal disease * Planned surgery - open hemorrhoidectomy * Absence of other anarectal diseases * I, II class of anesthetic risk according to ASA classification * Voluntary signing by the participant of an informed consent for surgical treatment and participation in a clinical trial.

Exclusion criteria

* Chronic or prolonged use of medications, including narcotic drugs, with analgesic effect for other diseases. * Patients who have contraindications or technical impossibility of performing subarachnoid anesthesia or the full standard volume of surgery for the corresponding disease. * Patients who refused to participate at any time before the end of the study, as well as patients who did not pass the final postoperative monitoring (1 month after the intervention). * Pregnant women * Complicated course of the postoperative period due to exacerbation of concomitant diseases

Design outcomes

Primary

MeasureTime frameDescription
Pain at rest and during defecationduring 10 days after surgeryThe pain was assessed using a visual analogue scale (VAS uses a 10 cm line with endpoint descriptors such as 'no pain' marked at the left end of the line and 'worst pain imaginable' marked at the right end)

Secondary

MeasureTime frameDescription
Other medications use10 days after surgeryThe frequency of other analgesics taken
Readmission rate30 days after surgeryThe number of cases of repeated appeals for relapse of the disease or hospitalizations
Rate of prescribing opioid analgesics3 days after surgerythe rate of prescribing opioid analgesics to prevent the pain from rising above VAS 5 after surgery (VAS uses a 10 cm line with endpoint descriptors such as 'no pain' marked at the left end of the line and 'worst pain imaginable' marked at the right end)
Complication ratewithin 30 days after surgeryCases of bleeding, urinary retention, infectious complications after surgery
Residual symptoms30 days after surgeryThe presence of residual symptoms after surgery
The life quality rate7 and 30 daysThe overall quality of life was assessed using the EQ-5D patient questionnaire. The EQ-5D-3L descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, and extreme problems.

Countries

Russia

Contacts

Primary ContactTatiana Garmanova, PhD
tatianagarmanova@gmail.com+79773429249
Backup ContactEkaterina Kazachenko, MD
ekaterina.k.97@mail.ru+79269721922

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026